Products
Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company, contributing to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the-art antibody technologies, in the core therapeutic areas of oncology, nephrology, central nervous system and immunology.
This page features main products from Kyowa Kirin worldwide portfolio and may not be available in all countries or regions, or may be approved for different indications, in different dosages, or in different strengths. In general, those products are available only by prescription through local healthcare professionals.
Please visit our local country or region website for local information:
Crysvita®
Crysvita® is a recombinant fully human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23 (FGF23).
By blocking excess FGF23 in patients, Crysvita® is intended to increase phosphate reabsorption in the kidney and increase the production of vitamin D, which enhances intestinal absorption of phosphate and calcium in patients with X linked hypophosphatemia.
POTELIGEO®
POTELIGEO® (mogamulizumab-kpkc) is a humanized monoclonal antibody (mAb) that targets CC chemokine receptor 4 (CCR4), which is frequently expressed on leukemic cells of certain hematologic malignancies including cutaneous T-cell lymphomas (CTCL), such as mycosis fungoides (MF) and Sézary syndrome (SS). By binding to CCR4 on malignant T-Cells, POTELIGEO® elicits an antitumor activity mediated by antibody-dependent cellular cytotoxicity (ADCC) leading to the death of malignant T-Cell.
POTELIGEO® was produced using Kyowa Kirin's proprietary POTELLIGENT® platform.
Nouriast®/ Nourianz®
NOURIANZ® (Istradefylline) is an Adenosine A2A receptor antagonist, which is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.
Production Technology
Our high-quality products come from our advanced production technology.
Find out how we manufacture our innovative products.